Search Results - "Kotteas, Elias A"

Tumor Dormancy: Implications for Invasion and Metastasis by Gomatou, Georgia, Syrigos, Nikolaos, Vathiotis, Ioannis A., Kotteas, Elias A.

“…Tumor dormancy refers to a critical stage of cancer development when tumor cells are present, but cancer does not progress. It includes both the concept of…”
Get full text

Management and outcomes in metaplastic breast cancer by Tzanninis, Ioannis-Georgios, Kotteas, E.A, Ntanasis-Stathopoulos, Ioannis, Kontogianni, Panagiota, Fotopoulos, George

“…Abstract Metaplastic breast cancer (MBC) constitutes a rare clinical entity with special clinicopathological, immunohistochemical and molecular features…”
Get full text

Assessment of Seroconversion after SARS-CoV-2 Vaccination in Patients with Lung Cancer by Trontzas, Ioannis P, Vathiotis, Ioannis, Economidou, Christina, Petridou, Ioulia, Gomatou, Georgia, Grammoustianou, Maria, Tsamis, Ioannis, Syrigos, Nikolaos, Anagnostakis, Maximilian, Fyta, Eleni, Sakka, Vissaria, Poulakou, Garyphalia, Kotteas, Elias A, Syrigou, Ekaterini

“…Background: SARS-CoV-2 mortality rates are significantly higher in patients with lung cancer compared with the general population. However, little is known on…”
Get full text

Bcl-2 pathway inhibition in solid tumors: a review of clinical trials by Ploumaki, Ioanna, Triantafyllou, Efthymios, Koumprentziotis, Ioannis-Alexios, Karampinos, Konstantinos, Drougkas, Konstantinos, Karavolias, Ioannis, Trontzas, Ioannis, Kotteas, Elias A.

“…Due to their key role in the pathogenesis of cancer through the regulation of apoptosis, the B-cell leukemia/lymphoma-2 (BCL-2) family proteins have been an…”
Get full text

The intercellular cell adhesion molecule-1 (icam-1) in lung cancer: implications for disease progression and prognosis by Kotteas, Elias A, Boulas, Panagiotis, Gkiozos, Ioannis, Tsagkouli, Sofia, Tsoukalas, George, Syrigos, Konstantinos N

“…The intercellular cell-adhesion molecule-1 (ICAM-1) is a transmembrane molecule and a distinguished member of the Immunoglobulin superfamily of proteins that…”
Get full text

Immune Checkpoint Blockade in Hormone Receptor-Positive Breast Cancer: Resistance Mechanisms and Future Perspectives by Vathiotis, Ioannis A., Trontzas, Ioannis, Gavrielatou, Niki, Gomatou, Georgia, Syrigos, Nikolaos K., Kotteas, Elias A.

Get full text

Optimizing diet and nutrition for cancer survivors: A review by Mourouti, Niki, Panagiotakos, Demosthenes B., Kotteas, Elias A., Syrigos, Konstantinos N.

“…•Cancer survivors are recommended to follow a plant-based diet.•Cancer survivors are recommended to limit their consumption of red meat, processed meat and…”
Get full text

Capecitabine-associated enterocolitis: Narrative literature review of a rare adverse event and a case presentation by Trontzas, Ioannis P, Rapti, Vasiliki E, Syrigos, Nikolaos K, Gomatou, Georgia, Lagou, Styliani, Kanellis, George, Kotteas, Elias A

“…Capecitabine is an oral 5-fluorouracil prodrug with antimetabolite activity commonly used in advanced colorectal and breast cancer. It presents with a…”
Get full text

The Emerging Role of Tyrosine Kinase Inhibitors in Ovarian Cancer Treatment: A Systematic Review by Ntanasis-Stathopoulos, Ioannis, Fotopoulos, George, Tzanninis, Ioannis-Georgios, Kotteas, Elias A.

“…The present systematic review summarizes current evidence regarding the mechanisms of action, the efficacy, and the adverse effects of tyrosine kinase…”
Get full text

Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors by Kotteas, Elias A, Syrigos, Konstantinos N, Saif, Muhammad Wasif

“…Neuroendocrine tumors are a rare and heterogeneous group of tumors with a variety of primary origins and variable aggressiveness. Platinum-based chemotherapy…”
Get full text

Takotsubo Cardiomyopathy in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Summary of Included Cases by Trontzas, Ioannis P, Vathiotis, Ioannis A, Kyriakoulis, Konstantinos G, Sofianidi, Amalia, Spyropoulou, Zoi, Charpidou, Andriani, Kotteas, Elias A, Syrigos, Konstantinos N

“…There are emerging reports of Takotsubo syndrome (TTS) in cancer patients treated with immune checkpoint inhibitors (ICIs); however, the association of the two…”
Get full text

The changing treatment of metastatic her2-positive breast cancer by Mitsogianni, Maria, Trontzas, Ioannis P, Gomatou, Georgia, Ioannou, Stephanie, Syrigos, Nikolaos K, Kotteas, Elias A

“…Human epidermal growth factor receptor 2 (HER2)-overexpressing breast cancer has been historically associated with an aggressive disease course with common…”
Get full text

Enteric plexus neuropathy associated with PD-L1 blockade in a patient with small-cell lung cancer by Trontzas, Ioannis P, Rapti, Vasiliki E, Syrigos, Nikolaos K, Kounadis, George, Perlepe, Nikoleta, Kotteas, Elias A, Bamias, Giorgos

“…Immune checkpoint inhibitors have revolutionized the management of patients with cancer. The increasing use of these agents has brought up a new set of adverse…”
Get full text

Soluble ICAM-1 levels in small-cell lung cancer: prognostic value for survival and predictive significance for response during chemotherapy by Kotteas, Elias A., Gkiozos, Ioannis, Tsagkouli, Sofia, Bastas, Antonios, Ntanos, Ioannis, Saif, Muhammad W., Syrigos, Konstantinos N.

“…Intercellular adhesion molecule-1 (ICAM-1) is an adhesion molecule, member of the immunoglobulin gene superfamily that seems to participate in the evolution of…”
Get full text

The expanding new era of cancer immunotherapy by Kotteas, Elias A., Syrigos, Konstantinos N.

Get full text

PET/CT and brain MRI role in staging NSCLC: prospective assessment of the accuracy, reliability and cost-effectiveness by Gkogkozotou, Vasiliki-Konstantina I, Gkiozos, Ioannis C, Charpidou, Andriani G, Kotteas, Elias A, Boura, Paraskevi G, Tsagouli, Sophia N, Syrigos, Konstantinos N

“…To determine whether PET/CT and brain MRI used in staging NSCLC can be accurate, reliable and cost-effective tools. NSCLC represents 80-85% of lung cancer and…”
Get full text

Targeted therapy for nonsmall cell lung cancer: focusing on angiogenesis, the epidermal growth factor receptor and multikinase inhibitors by Kotteas, Elias A, Charpidou, Andriani G, Syrigos, Kostas N

“…Chemotherapy used to be the only available option to fight advanced nonsmall cell lung cancer. Platinum-based medication combined with taxanes, vinca…”
Get full text

CDK4/6 inhibitors and cardiovascular toxicity: Real-world evidence by Fiste, Oraianthi, Liontos, Michael, Gavriatopoulou, Maria, Dimitrakakis, Constantine, Evangelou, George, Nikolaidou, Vasiliki, Kotteas, Elias A., Syrigos, Kostas N., Dimopoulos, Meletios A., Zagouri, Flora

“…e15074 Background: Cyclin-dependent kinases 4/6 inhibitors (CDK4/6i) have fundamentally transformed the therapeutic landscape of hormone receptor-positive and…”
Get full text

Capecitabine-associated enterocolitis: Narrative literature review of a rare adverse event and a case presentation by Trontzas, Ioannis P., Rapti, Vasiliki E., Syrigos, Nikolaos K., Gomatou, Georgia, Lagou, Styliani, Kanellis, George, Kotteas, Elias A.

“…Capecitabine is an oral 5-fluorouracil prodrug with antimetabolite activity commonly used in advanced colorectal and breast cancer. It presents with a…”
Get full text